Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV

Anemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT...

Full description

Bibliographic Details
Main Authors: Danis Pertiwi, Muchlis Achsan Udji Sofro, Tri Indah Winarni, Ari Natalia Probandari
Format: Article
Language:English
Published: Universitas Sanata Dharma 2023-05-01
Series:Jurnal Farmasi Sains dan Komunitas
Subjects:
Online Access:https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331
_version_ 1797785711412248576
author Danis Pertiwi
Muchlis Achsan Udji Sofro
Tri Indah Winarni
Ari Natalia Probandari
author_facet Danis Pertiwi
Muchlis Achsan Udji Sofro
Tri Indah Winarni
Ari Natalia Probandari
author_sort Danis Pertiwi
collection DOAJ
description Anemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT consumption duration and the incidence of anemia in HIV-infected individuals. This cross-sectional study was conducted at health service facilities using 213 participants. The data were obtained from medical records, and the assessed parameter was hemoglobin (Hb) level after less or more than a year of zidovudine administration. Furthermore, they were analyzed using a Pearson’s coefficient contingency test (p0.05) to evaluate the correlation between groups with and without anemia at each period of drug administration. The results showed a significant correlation (p0.05) between sex and age with anemia incidence in HIV patients administered AZT. The duration of this drug intake in HIV-infected individuals was correlated with anemia (p= 0.024; OR=0.369). This indicates the use of AZT for at least one year may be a protective factor for the incidence of anemia in patients with HIV compared to the group consuming this drug for less than one year.
first_indexed 2024-03-13T00:58:49Z
format Article
id doaj.art-2a8a8cfd5422446f9a8ab92f64417e1f
institution Directory Open Access Journal
issn 1693-5683
2527-7146
language English
last_indexed 2024-03-13T00:58:49Z
publishDate 2023-05-01
publisher Universitas Sanata Dharma
record_format Article
series Jurnal Farmasi Sains dan Komunitas
spelling doaj.art-2a8a8cfd5422446f9a8ab92f64417e1f2023-07-06T13:56:39ZengUniversitas Sanata DharmaJurnal Farmasi Sains dan Komunitas1693-56832527-71462023-05-01201465110.24071/jpsc.0043312950Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIVDanis Pertiwi0Muchlis Achsan Udji Sofro1Tri Indah Winarni2Ari Natalia Probandari3Department of Clinical Pathology, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, IndonesiaDivision of Tropical Medicine Department of Internal Medicine Dr Kariadi Hospital, Faculty of Medicine Universitas Diponegoro, Semarang, IndonesiaDepartment of Anatomy, Faculty of Medicine, Universitas Diponegoro, Semarang, IndonesiaDepartment of Public Health, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, IndonesiaAnemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT consumption duration and the incidence of anemia in HIV-infected individuals. This cross-sectional study was conducted at health service facilities using 213 participants. The data were obtained from medical records, and the assessed parameter was hemoglobin (Hb) level after less or more than a year of zidovudine administration. Furthermore, they were analyzed using a Pearson’s coefficient contingency test (p0.05) to evaluate the correlation between groups with and without anemia at each period of drug administration. The results showed a significant correlation (p0.05) between sex and age with anemia incidence in HIV patients administered AZT. The duration of this drug intake in HIV-infected individuals was correlated with anemia (p= 0.024; OR=0.369). This indicates the use of AZT for at least one year may be a protective factor for the incidence of anemia in patients with HIV compared to the group consuming this drug for less than one year.https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331hivanemiazidovudine consumptionduration
spellingShingle Danis Pertiwi
Muchlis Achsan Udji Sofro
Tri Indah Winarni
Ari Natalia Probandari
Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
Jurnal Farmasi Sains dan Komunitas
hiv
anemia
zidovudine consumption
duration
title Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
title_full Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
title_fullStr Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
title_full_unstemmed Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
title_short Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
title_sort duration of zidovudine consumption correlates with anemia in people living with hiv
topic hiv
anemia
zidovudine consumption
duration
url https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331
work_keys_str_mv AT danispertiwi durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv
AT muchlisachsanudjisofro durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv
AT triindahwinarni durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv
AT arinataliaprobandari durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv